Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination.

Item

http://www.wikidata.org/entity/Q38544744

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination.

@en

type

Item

label

Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination.

@en

prefLabel

Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination.

@en

P1476

Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination.

@en

P2093

Allana J Sucher

http://www.w3.org/2001/XMLSchema#string

Elias B Chahine

http://www.w3.org/2001/XMLSchema#string

Matthew Fete

http://www.w3.org/2001/XMLSchema#string

Peter Cogan

http://www.w3.org/2001/XMLSchema#string

P2860

10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America

Three decades of beta-lactamase inhibitors

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Impact of renal function on the pharmacokinetics and safety of ceftolozane-tazobactam.

Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.

Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus.

Pharmacokinetics and safety of CXA-101, a new antipseudomonal cephalosporin, in healthy adult male and female subjects receiving single- and multiple-dose intravenous infusions.

Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections.

Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.

Impact of MIC range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the ceftolozane in vivo pharmacokinetic/pharmacodynamic target.

P304

1046-1056

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1060028015593293

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26160970

http://www.w3.org/2001/XMLSchema#string